Web based requisition software | Accounting information systems

Our latest news:

Cardax Pharmaceuticals
Streamlines Business
Operations with
TRxLink™ from e-BizSoft

e-BizSoft, Inc.
Releases Latest Version of TRxLink™

PEMBROKE PINES, FL — Cardax Pharmaceuticals, Inc., a leading drug discovery and development company, and e-BizSoft, Inc., a leading business software solution provider, announced today that Cardax Pharmaceuticals is successfully utilizing e-BizSoft’s TRxLink™ application to manage and optimize its requisition process.

TRxLink™ is a powerful web-based application service designed to enable leading companies to streamline their requisition process and save time, effort, and money. With an easy-to-use interface, TRxLink™ enables multiple users in an organization to initiate, review, and approve requisitions, as well as create purchase orders in their organization’s ERP application. Plus, its highly-sophisticated, rule-driven engine enables administrators to apply specific business rules to their organization.

“Prior to TRxLink™, we were using a custom Microsoft Access-based application, which offered basic requisition tools, but lacked electronic routing and integration with our accounting software,” says David M. Watumull, Program Manager, Cardax Pharmaceuticals. “We made the strategic decision to use TRxLink™ because it offers advanced features such as electronic approval routing, automatic e-mail notifications, and synchronization with QuickBooks®, which enable our team to operate more efficiently.”

“e-BizSoft is pleased that Cardax Pharmaceuticals is utilizing Transaction Link™ to manage their requisition process and achieve their business operation goals,” says Arif Ahmed, President & CEO, e-BizSoft, Inc. “Transaction Link™ is designed to make a company’s requisition process seamless, while ensuring consistency and accuracy and improving overall operational efficiency.”

About Cardax Pharmaceuticals, Inc. Cardax Pharmaceuticals is a drug discovery and development company targeting large un-met medical needs where inflammation plays a crucial and often newly defined pivotal role. While most anti-inflammatory treatments have significant long-term side effects that limit their utility, Cardax Pharmaceuticals has developed a novel approach to treating inflammation that is inherently safer, yet highly effective. The company’s first product targets cardiovascular disease, the largest sector of the pharmaceutical industry.

TRxLink. Requisition Software.